Literature DB >> 11985665

Crucial Fas-Fas ligand interaction in spontaneous acceptance of hepatic allografts in mice.

Hideaki Uchiyama1, Kenji Kishihara, Ryosuke Minagawa, Koji Hashimoto, Keizo Sugimachi, Kikuo Nomoto.   

Abstract

The Fas/Fas ligand (FasL) system plays important roles in the immune system, including host immunoregulation and cytotoxicity. In this study, we investigated the involvement of Fas-FasL interactions in spontaneous acceptance of hepatic allografts in murine orthotopic liver transplantation. Liver transplantation between the C57BL/6 (B6, H-2b) donor and the MRL/Mp (MRL, H-2k) recipient was performed in various combinations of donor and recipient mice with wild type (+/+), Fas-mutant (lpr) or FasL-mutant (gld) genotypes. The prolongation and spontaneous acceptance of the fully allogeneic grafts in recipients was not observed in either MRL-lpr recipients with B6+/+ livers or MRL+/+ recipients with B6-gld livers. Moreover, the serum alanine aminotransferase (ALT) levels and the degree of cell infiltration into hepatic allografts on day 7 after transplantation were inversely correlated with the recipient survival time (in days). The donor-specific cytotoxic T-lymphocyte (CTL) activities of the graft-infiltrating cells (GICs) from MRL-gld recipients with B6+/+ livers were much lower than those from MRL+/+ or -lpr recipients on days 5 and 10 after transplantation. However, the CTL activities of the GICs from MRL+/+ and -gld recipients predominantly disappeared by day 15 after transplantation. Furthermore, the anti-donor CTL activities induced in MRL+/+ recipients were ascribed to CD8+ cells, and were not mediated by Fas-FasL interactions. These results strongly suggest that the Fas/FasL system plays a critical role for recipient immunoregulation, enabling recipients in accepting hepatic allografts by deletion of the donor-specific T cells, but not for CTL/target cell interaction in MRL+/+ recipients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11985665      PMCID: PMC1782688          DOI: 10.1046/j.1365-2567.2002.01388.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  36 in total

1.  Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.

Authors:  T Brunner; R J Mogil; D LaFace; N J Yoo; A Mahboubi; F Echeverri; S J Martin; W R Force; D H Lynch; C F Ware
Journal:  Nature       Date:  1995-02-02       Impact factor: 49.962

2.  Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes.

Authors:  H Kojima; N Shinohara; S Hanaoka; Y Someya-Shirota; Y Takagaki; H Ohno; T Saito; T Katayama; H Yagita; K Okumura
Journal:  Immunity       Date:  1994-08       Impact factor: 31.745

3.  Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways.

Authors:  B Lowin; M Hahne; C Mattmann; J Tschopp
Journal:  Nature       Date:  1994-08-25       Impact factor: 49.962

4.  A role for CD95 ligand in preventing graft rejection.

Authors:  D Bellgrau; D Gold; H Selawry; J Moore; A Franzusoff; R C Duke
Journal:  Nature       Date:  1995-10-19       Impact factor: 49.962

5.  Apoptosis as a mechanism of cell death in liver allograft rejection.

Authors:  S M Krams; H Egawa; M B Quinn; J C Villanueva; R Garcia-Kennedy; O M Martinez
Journal:  Transplantation       Date:  1995-02-27       Impact factor: 4.939

6.  Fas-mediated cytotoxicity. An immunoeffector or immunoregulatory pathway in T cell-mediated immune responses?

Authors:  C P Larsen; D Z Alexander; R Hendrix; S C Ritchie; T C Pearson
Journal:  Transplantation       Date:  1995-08-15       Impact factor: 4.939

7.  Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis.

Authors:  D W Nicholson; A Ali; N A Thornberry; J P Vaillancourt; C K Ding; M Gallant; Y Gareau; P R Griffin; M Labelle; Y A Lazebnik
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

Review 8.  Fas and Fas ligand: lpr and gld mutations.

Authors:  S Nagata; T Suda
Journal:  Immunol Today       Date:  1995-01

9.  Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

Authors:  S T Ju; D J Panka; H Cui; R Ettinger; M el-Khatib; D H Sherr; B Z Stanger; A Marshak-Rothstein
Journal:  Nature       Date:  1995-02-02       Impact factor: 49.962

10.  Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome.

Authors:  J L Chu; P Ramos; A Rosendorff; J Nikolić-Zugić; E Lacy; A Matsuzawa; K B Elkon
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Lessons and limits of mouse models.

Authors:  Anita S Chong; Maria-Luisa Alegre; Michelle L Miller; Robert L Fairchild
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

2.  OVA-specific CD8+ T cells do not express granzyme B during anterior chamber associated immune deviation.

Authors:  Yalin Ren; Peizeng Yang; Bing Li; Yang Gao; Hongyan Zhou; Xiangkun Huang; Lianxiang Zhu; Aize Kijlstra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-15       Impact factor: 3.117

3.  Inhibition of mouse hepatocyte apoptosis via anti-Fas ribozyme.

Authors:  Min Zhang; Wei He; Fang Liu; Ping Zou; Juan Xiao; Zhao-Dong Zhong; Zhong-Bo Hu
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

Review 4.  Liver transplantation in the mouse: Insights into liver immunobiology, tissue injury, and allograft tolerance.

Authors:  Shinichiro Yokota; Osamu Yoshida; Yoshihiro Ono; David A Geller; Angus W Thomson
Journal:  Liver Transpl       Date:  2016-04       Impact factor: 5.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.